<DOC>
	<DOCNO>NCT00856882</DOCNO>
	<brief_summary>The investigator propose perform double-blind , randomize placebo-controlled trial examine hypothesis soy protein isoflavones could improve glycemic control , insulin sensitivity decrease cardiovascular risk factor postmenopausal woman prediabetes .</brief_summary>
	<brief_title>The Effects Soy Protein Isoflavones Glycemic Control , Insulin Sensitivity Cardiovascular Risk Factors</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Hong Kong Chinese menopausal woman age 4670 year prediabetes early untreated diabetes Women breast , ovary cancer recent 5year Severe renal liver dysfunction Women androgen excess Smokers Current use recent ( 3month ) use drug treatment glycemic control , lipid improvement , weight reduction ; Subjects know soy milk allergy .</criteria>
	<gender>Female</gender>
	<minimum_age>46 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>